KiraGen Bio
KiraGen Bio is a biotech company. It has 1 recorded funding round.
Multiplex-Edited CAR-T for Solid Tumors
- Website
- kiragenbio.com
- Rounds
- 1
Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.
About
KiraGen Bio engineers healthy-donor CAR-T cells for solid-tumor cell therapy, starting with recurrent glioblastoma. Its approach focuses on making these engineered cells resistant to the signals tumors use to shut them down. KiraGen describes its therapeutic aim as programmable durability, centering its work on resistance to tumor suppression.
Summary
Investors include ZAKA VC and Gaingels.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/kiragen-bio"><img src="https://indexed.vc/api/badge/company/kiragen-bio" alt="KiraGen Bio on Indexed.vc" width="260" height="76" /></a>
